Citation Impact
Citing Papers
The Metabolic Syndrome and Inflammation
2004
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Inflammation: the link between insulin resistance, obesity and diabetes
2003 Standout
Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
1993 Standout
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
2015 Standout
TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction
2004 StandoutNobel
The pro- and anti-inflammatory properties of the cytokine interleukin-6
2011 Standout
The metabolic syndrome
2010 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Hemobiology, vascular disease, and diabetes with special reference to impaired fibrinolysis
1992
Propagation, rethrombosis and new thrombus formation after acute deep venous thrombosis
1995
Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance
2000
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Obesity
2005 Standout
The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones
1995
The metabolic syndrome
2005 Standout
Safety Considerations with Fibrate Therapy
2006
Tissue Plasminogen Activator Contributes to the Late Phase of LTP and to Synaptic Growth in the Hippocampal Mossy Fiber Pathway
1998 StandoutNobel
Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance
2005
Fibrinolytic response in normal subjects to venous occlusion and DDAVP infusion
1989
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
High–monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations
1999 Standout
The relationships of concentrations of insulin, intact proinsulin and 32?33 split proinsulin with cardiovascular risk factors in Type 2 (non-insulin-dependent) diabetic subjects
1990
Resistance to Activated Protein C as a Basis for Venous Thrombosis
1994 Standout
Polycystic Ovary Syndrome
2005 Standout
Impaired fibrinolysis in coronary artery disease
1988
Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta.
1991
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1
2004
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
1992 Standout
The Human Plasma Proteome
2002 Standout
PROTEIN C DEFICIENCY AND PORTAL THROMBOSIS IN LIVER TRANSPLANTATION IN CHILDREN
1988
Stimulatory effect of unsaturated fatty acids on the level of plasminogen activator inhibitor‐1 mRNA in cultured human endothelial cells
1995 StandoutNobel
Biochemical and biological aspects of the plasminogen activation system
1990
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Coagulation and Fibrinolysis during the Normal Menstrual Cycle
1989
The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance
1993
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
Effect of Troglitazone on Fibrinolysis and Activated Coagulation in Patients With Non–Insulin-Dependent Diabetes Mellitus
1998
Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis
1992 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
1995 Standout
Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.
1990
The Complex Role of Estrogens in Inflammation
2007 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Maturation of the hemostatic system during childhood
1992 Standout
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
1993
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
A Critical Review of the Evidence Supporting a Relationship Between Impaired Fibrinolytic Activity and Venous Thromboembolism
1991
Diabetes and Endothelial Dysfunction: A Clinical Perspective
2001
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
2009 Standout
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Dependence of Augmentation of Arterial Endothelial Cell Expression of Plasminogen Activator Inhibitor Type 1 by Insulin on Soluble Factors Released From Vascular Smooth Muscle Cells
1997
Age Dependence of Blood Fibrinolytic Components and the Effects of Low-Dose Oral Contraceptives on Coagulation and Fibrinolysis in Teenagers
1988
Insulin Stimulates the Synthesis of Plasminogen Activator Inhibitor 1 by the Human Hepatocellular Cell Line Hep G2
1988
Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
1988
Relationship between Adipocyte Size and Adipokine Expression and Secretion
2006
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.
1989
Atherosclerosis: Basic Mechanisms
1995 Standout
A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers
1989
Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
1990
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Understanding Adipocyte Differentiation
1998 Standout
Determinants of Plasma Levels of Plasminogen Activator Inhibitor-1
1999
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Spontaneous lysis of deep venous thrombi: rate and outcome
1989
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
2000 Standout
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
2000
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
1993 Standout
Pharmacologic Therapy for Type 2 Diabetes Mellitus
1999
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Elaboration of Type-1 Plasminogen Activator Inhibitor From Adipocytes
1996
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Pathophysiology of Sleep Apnea
2010 Standout
Investigation of Chronic Venous Insufficiency
2000 Standout
Insulin and Cardiovascular Disease: Paris Prospective Study
1991
Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.
1995
Deep venous insufficiency: The relationship between lysis and subsequent reflux
1993
The Metabolic Syndrome
2008 Standout
Minireview: Adiposity, Inflammation, and Atherogenesis
2003
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Monounsaturated Fatty Acid–Enriched Diet Decreases Plasma Plasminogen Activator Inhibitor Type 1
1996
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells.
1991
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
Thromboembolic Disease – Critical Evaluation of Laboratory Investigation
1992
Stability of Plasminogen Activator Inhibitor 1 (PAI-1)
1989 StandoutNobel
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.
1992
Works of J Valadier being referenced
Relevance of Free tPA Assay Following Venous Occlusion in Patients with Venous Thromboembolic Disease
1988
Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis
1987
Metformin Decreases the High Plasminogen Activator Inhibition Capacity, Plasma Insulin and Triglyceride Levels in Non-Diabetic Obese Subjects
1987
Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
1987